Table 2.

Frequencies reflecting medical student knowledge about the HPV vaccine. (N=231)

	Total n (%) correct	Vaccinated, n (%) correct	Unvaccinated, n (%) correct	p-value
Statements of fact^a, ^b		n=97	n=134
Almost all cervical cancers are caused by HPV infection. (A) (n=223)	196 (87.9)	84 (89.4)	112 (86.8)	0.57
The prevalence of HPV infection is highest among women in their 30s.(D) (n=210)	112 (53.3)	52 (55.9)	60 (51.3)	0.5
Most people with genital HPV infections have symptoms. (D) (n=228)	217 (95.2)	93 (95.9)	124 (94.7)	0.23^c
Genital warts are caused by the same HPV types that cause cervical cancer. (D) (n=223)	176 (78.9)	72 (78.3)	104 (79.4)	0.84
Sexually active women should be tested for HPV before getting the HPV vaccine. (D) (n=208)	152 (73.1)	68 (75.6)	84 (71.2)	0.48
Women who have been diagnosed with HPV infection should not be given the HPV vaccine. (D) (n=189)	159 (84.1)	74 (87.1)	85 (81.7)	0.32
If a patient received only 1 HPV vaccine dose >1 year ago, they should restart the 3-dose series. (D) (n=175)	44 (25.1)	19 (23.5)	25 (26.6)	0.63
The HPV vaccine is FDA approved for women up to 30 years of age. (D) (n=194)	102 (52.6)	47 (54.6)	55 (50.9)	0.61
White women have the highest incidence of cervical cancer in the US. (D) (n=165)	98 (59.4)	47 (61.8)	51 (57.3)	0.55
Physician recommendation is the most important facilitator for HPV vaccination. (A) (n=222)	195 (87.8)	78 (83.9)	117 (90.7)	0.12
Side effects of the HPV vaccine are minor. (A) (n=222)	212 (95.5)	89 (95.7)	123 (95.4)	0.25^c

HPV – human papillomavirus; A – Agree; D – Disagree. “Vaccinated” indicates at least one dose of the HPV vaccine was received. Number of respondents indicated in parentheses after the statement.

Denominator may vary due to missing responses.

Correct responses are indicated by A (Agree) or D (Disagree) after each statement.

Fisher's Exact test used for comparisons because some cell counts < 5.